Vaccination approaches to combat human metapneumovirus lower respiratory tract infections

Journal of Clinical Virology

Volumn 41, Issue 1, 2008, Pages 49-52

  Herfst, Sander ^a   Fouchier, Ron A M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Animals; Immunization; Metapneumovirus; Protective efficacy; Vaccine

Indexed keywords

INACTIVATED VACCINE; LIVE VACCINE; SUBUNIT VACCINE; VIRUS VACCINE; VIRUS VECTOR;

ARTICLE; DRUG EFFICACY; HUMAN METAPNEUMOVIRUS; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; HUMANS; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; PRIMATES; RESPIRATORY TRACT INFECTIONS; RODENTIA; VACCINES, ATTENUATED; VACCINES, SUBUNIT; VIRAL VACCINES;

EID: 37349072513     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.10.022     Document Type: Article

References (19)

1. Biacchesi S., Skiadopoulos M.H., Tran K.C., Murphy B.R., Collins P.L., and Buchholz U.J. Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes. Virology 321 (2004) 247-259
2. Biacchesi S., Skiadopoulos M.H., Yang L., Lamirande E.W., Tran K.C., Murphy B.R., et al. Recombinant human metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol 78 (2004) 12877-12887
3. Biacchesi S., Pham Q.N., Skiadopoulos M.H., Murphy B.R., Collins P.L., and Buchholz U.J. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol 79 (2005) 12608-12613
4. Buchholz U.J., Biacchesi S., Pham Q.N., Tran K.C., Yang L., Luongo C.L., et al. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity. J Virol 79 (2005) 6588-6597
5. Cseke G., Wright D.W., Tollefson S.J., Johnson J.E., Crowe Jr. J.E., and Williams J.V. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J Virol 81 (2007) 698-707
6. Herfst S., de Graaf M., Schickli J.H., Tang R.S., Kaur J., Yang C.F., et al. Recovery of human metapneumovirus genetic lineages A and B from cloned cDNA. J Virol 78 (2004) 8264-8270
7. Herfst S., de Graaf M., Schrauwen E.J., Ulbrandt N., Barnes A.S., Senthil K., et al. Immunization of Syrian golden hamsters with F subunit vaccine of human metapneumovirus induces protection against challenge with homologous or heterologous strains. J Gen Virol 88 (2007) 2702-2709
8. Karron R.A., Wright P.F., Hall S.L., Makhene M., Thompson J., Burns B.A., et al. A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J Infect Dis 171 (1995) 1107-1114
9. Kim H.W., Canchola J.G., Brandt C.D., Pyles G., Chanock R.M., Jensen K., et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89 (1969) 422-434
10. Pham Q.N., Biacchesi S., Skiadopoulos M.H., Murphy B.R., Collins P.L., and Buchholz U.J. Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo. J Virol 79 (2005) 15114-15122
11. Skiadopoulos M.H., Biacchesi S., Buchholz U.J., Amaro-Carambot E., Surman S.R., Collins P.L., et al. Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. Virology 345 (2006) 492-501
12. Tang R.S., Schickli J.H., MacPhail M., Fernandes F., Bicha L., Spaete J., et al. Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity. J Virol 77 (2003) 10819-10828
13. Tang R.S., Mahmood K., Macphail M., Guzzetta J.M., Haller A.A., Liu H., et al. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys. Vaccine 23 (2005) 1657-1667
14. van den Hoogen B.G., de Jong J.C., Groen J., Kuiken T., de Groot R., Fouchier R.A., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7 (2001) 719-724
15. van den Hoogen B.G., Doornum G.J.Jv., Fockens J.C., Cornelissen J.J., Beyer W.E.P., Groot R.d., et al. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis (2003) 188
16. van den Hoogen B.G., Herfst S., Sprong L., Cane P.A., Forleo E., de Swart R.L., et al. Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis 10 (2004) 658-666
17. van den Hoogen B.G., Herfst S., de Graaf M., Sprong L., van Lavieren R., van Amerongen G., et al. Experimental infection of macaques with human metapneumovirus induces transient protective immunity. J Gen Virol 88 (2007) 1251-1259
18. Williams J.V., Wang C.K., Yang C.F., Tollefson S.J., House F.S., Heck J.M., et al. The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis 193 (2006) 387-395
19. Yim K.C., Cragin R.P., Boukhvalova M.S., Blanco J.C., Hamlin M.E., Boivin G., et al. Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged. Vaccine 25 (2007) 5034-5040